Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
52
IRWD Quote, Financials, Valuation and Earnings
Last price:
$0.80
Seasonality move
:
-9.62%
Day range:
$0.73 - $0.82
52-week range:
$0.53 - $7.11
Dividend yield:
0%
P/E ratio:
126.50x
P/S ratio:
0.40x
P/B ratio:
--
Volume:
1.1M
Avg. volume:
2.2M
1-year change:
-88.4%
Market cap:
$128M
Revenue:
$351.4M
EPS (TTM):
-$0.20
Earnings Data
Next earnings date for IRWD
Aug 08
2025
Most recent earnings per share
-$0.23
Missed by $0.20
(May 7/2025)
Consensus Estimate
-$0.03
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IRWD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $77.8M | -- | -- | $0.13 | -- |
| 08/08/2025 | Q2 | $62M | -- | -- | $0.04 | -- |
| 05/07/2025 | Q1 | $56.7M | $41.1M | -$0.23 | -$0.03 | -$0.20 |
| 02/27/2025 | Q4 | $93.9M | $90.5M | $0.02 | $0.08 | -$0.06 |
| 11/07/2024 | Q3 | $91.3M | $91.6M | $0.02 | $0.10 | -$0.08 |
| 08/08/2024 | Q2 | $107M | $94.4M | -$0.01 | $0.14 | -$0.15 |
| 05/09/2024 | Q1 | $105.8M | $74.9M | -$0.03 | $0.15 | -$0.18 |
| 02/15/2024 | Q4 | $117.4M | $117.6M | -$0.01 | $0.20 | -$0.21 |
| 11/09/2023 | Q3 | -- | -- | $0.09 | $0.16 | -$0.07 |
| 08/08/2023 | Q2 | -- | -- | -$6.84 | $0.25 | -$7.09 |
| 05/04/2023 | Q1 | -- | -- | $0.25 | $0.24 | $0.01 |
| 02/16/2023 | Q4 | -- | -- | $0.27 | $0.26 | $0.01 |
| 11/03/2022 | Q3 | -- | -- | $0.28 | $0.27 | $0.01 |
| 08/04/2022 | Q2 | -- | -- | $0.21 | $0.30 | -$0.09 |
| 05/05/2022 | Q1 | -- | -- | $0.21 | $0.26 | -$0.05 |
| 02/17/2022 | Q4 | -- | -- | $0.25 | $0.34 | -$0.09 |
| 11/04/2021 | Q3 | -- | -- | $0.34 | $0.32 | $0.02 |
| 08/05/2021 | Q2 | -- | -- | $2.39 | $0.22 | $2.17 |
| 05/06/2021 | Q1 | -- | -- | $0.25 | $0.22 | $0.04 |
| 02/17/2021 | Q4 | -- | -- | $0.27 | $0.29 | -$0.02 |
| 11/05/2020 | Q3 | -- | -- | $0.21 | $0.15 | $0.06 |
| 08/06/2020 | Q2 | -- | -- | $0.16 | $0.10 | $0.06 |
| 05/06/2020 | Q1 | -- | -- | $0.02 | $0.05 | -$0.03 |
| 02/13/2020 | Q4 | -- | -- | $0.30 | $0.24 | $0.06 |
| 10/31/2019 | Q3 | -- | -- | $0.13 | $0.12 | $0.01 |
| 07/30/2019 | Q2 | -- | -- | $0.08 | -$0.03 | $0.11 |
| 05/02/2019 | Q1 | -- | -- | -$0.38 | -$0.23 | -$0.15 |
| 02/13/2019 | Q4 | -- | -- | -$0.10 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$1.14 | -- | -- |
| 08/06/2018 | Q2 | -- | -- | -$0.32 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | -$0.29 | -- | -- |
| 02/15/2018 | Q4 | -- | -- | $0.08 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$0.22 | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -$0.30 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$0.36 | -- | -- |
| 02/21/2017 | Q4 | -- | -- | -$0.09 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | -$0.23 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.15 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.09 | -- | -- |
| 02/18/2016 | Q4 | -- | -- | -$0.09 | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -$0.33 | -- | -- |
Ironwood Pharmaceuticals Earnings Questions
-
How Much did Ironwood Pharmaceuticals Generate in Revenue Last Quarter?
Ironwood Pharmaceuticals reported $41.1M worth of top line sales in its most recent quarter.
-
Did Ironwood Pharmaceuticals Beat Earnings Last Quarter?
Ironwood Pharmaceuticals announced earnings per share of -$0.23 which represents a miss of analyst forecast a -$0.03 per share.
-
Is Ironwood Pharmaceuticals Profitable?
Ironwood Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Ironwood Pharmaceuticals EPS Next Year?
Ironwood Pharmaceuticals's earnings are forecast to grow from $0.01 per share to $0.09 per share next year representing an increase of 1750%.
-
When is Ironwood Pharmaceuticals's Earnings Date?
Ironwood Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
